!!! DISCUSSION GROUP RULES !!!

1. You must be a registered website user in order to post and comment. Guests may read only.
2. Be kind and helpful, not rude and cynical.
3. Don't advertise or promote anything. You will be banned from the group.
4. Report problems to the moderators. THANK YOU!

Has anyone access to BJH-Articles?

More
14 years 4 months ago #18849 by DeltaElite
Has anyone access to BJH-Articles? was created by DeltaElite
Hi everyone. Does anyone have access or does know a way to get the following article:

"Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents." Br J Haematology, 2011 Sep 9, Ghanima W et al

Thanks

Please Log in or Create an account to join the conversation.

More
14 years 4 months ago #18856 by eklein
Replied by eklein on topic Re: Has anyone access to BJH-Articles?
You could contact your local public library and they could help you get the article.
Erica

And she was!
Diagnosed May 2005, lowest count 8K.
4/22/08: 43K (2nd Rituxan)
10/01/09: 246K, 1/8/10: 111K, 5/21/10: 233K
Latest count: 7/27/2015: 194K

Please Log in or Create an account to join the conversation.

  • Sandi
  • Offline
  • Sandi Forum Moderator Diagnosed in 1998, currently in remission. Diagnosed with Lupus in 2006. Last Count - 344k - 6-9-18
More
14 years 4 months ago #18867 by Sandi
Replied by Sandi on topic Re: Has anyone access to BJH-Articles?
Here is an abstract:

Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents. [JOURNAL ARTICLE]
Br J Haematol 2011 Sep 9.


This study assessed the grade of bone marrow (BM) fibrosis and its association with a seromarker for collagen-III formation and fibrosis-related cytokines in 25 immune thrombocytopenia (ITP) patients treated with thrombopoietin receptor agonists (Tpo-RA) who had at least one BM biopsy. Assessment of 8 pre- and on-treatment BM biopsies revealed statistically significant increases in reticulin. Reticulin in biopsies performed after a median of 1·4 years of treatment was graded: MF-0 in 3 (12%), MF-1 in 19 (76%), MF-2 in 2 (8%) and MF-3 in 1 (4%). No cytogenetic or flow-cytometric abnormalities were detected. Median pretreatment Procollagen III N-propeptide (PIIINP) (6·6 μg/l) was significantly higher than on-treatment levels (5·6 μg/l); both were higher than controls (3·4 μg/l; P < 0·001). PIIINP was negatively correlated with treatment duration (r = -0·49) suggesting a decelerated reticulin production over time. There was a trend towards an association between grade of reticulin and PIIINP. Transforming growth factor (GF)-beta and basic-Fibroblast GF were not different between patients and controls but Hepatocyte GF (HGF), an anti-fibrotic cytokine, was significantly elevated in patients. In conclusion, low-grade BM reticulin fibrosis is seen in most ITP patients on Tpo-RA. The novel findings of decreasing PIIINP and elevated HGF need further investigation to explore their significance in BM fibrogenesis.


www.unboundmedicine.com/medline/ebm/record/21902682/abstract/Fibroproliferative_activity_in_patients_with_immune_thrombocytopenia__ITP__treated_with_thrombopoietic_agents_

Please Log in or Create an account to join the conversation.

More
14 years 4 months ago #18872 by DeltaElite
Replied by DeltaElite on topic Re: Has anyone access to BJH-Articles?
Thanks Sandi,

i already read the abstract. Would have liked to read the full. Haven't got access to BJH. Only NEJM, Blood etc.

Please Log in or Create an account to join the conversation.

More
14 years 4 months ago #18874 by Ann
MY nhs athens login doesn't seem to work for that which is pretty pathetic really. But there you go.

Please Log in or Create an account to join the conversation.

You’re not alone. We have answers! Contact PDSA to connect with life altering information, resources and referrals. 440.746.9003 (877.528.3538 toll-free) or PDSA@PDSA.org.

Platelet Disorder Support Association

Platelet Disorder Support Association
8751 Brecksville Road Suite 150
Cleveland, OH 44141
440.746.9003  |  pdsa@pdsa.org
The Platelet Disorder Support Association is a 501(c)3 organization and donations are tax deductible to the fullest extent allowed by law.

IMPORTANT!

The Platelet Disorder Support Association does not provide medical advice or endorse any medication, vitamins or herbs. The information contained herein is not intended nor implied to be a substitute for professional medical advice and is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider before starting any new treatment, discontinuing an existing treatment and to discuss any questions you may have regarding your unique medical condition.